Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM
-
Number of holders
-
49
-
Total 13F shares, excl. options
-
20,809,814
-
Shares change
-
+1,311,829
-
Total reported value, excl. options
-
$101,969,985
-
Value change
-
+$6,420,332
-
Put/Call ratio
-
0.64%
-
Number of buys
-
29
-
Number of sells
-
-11
-
Price
-
$4.90
Significant Holders of ARGOS THERAPEUTICS INC - COM (ARGS) as of Q4 2016
57 filings reported holding ARGS - ARGOS THERAPEUTICS INC - COM as of Q4 2016.
ARGOS THERAPEUTICS INC - COM (ARGS) has 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20,809,814 shares
.
Largest 10 shareholders include Pharmstandard International S.A. (13,242,279 shares), WASATCH ADVISORS INC (3,254,211 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (1,024,428 shares), VANGUARD GROUP INC (782,336 shares), BlackRock Fund Advisors (455,673 shares), SANDERS MORRIS HARRIS INC. (292,512 shares), STATE STREET CORP (177,494 shares), ALTRINSIC GLOBAL ADVISORS LLC (172,505 shares), GEODE CAPITAL MANAGEMENT, LLC (153,065 shares), and BlackRock Institutional Trust Company, N.A. (149,302 shares).
This table shows the top 49 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.